Daily non-political popular news in brief.

10 Top Australian Scientists Predict Major Medical Advances

10-10-2006 · ScienceDaily

Australians will soon be able to find out how good their genes are at fighting disease, what risks they are susceptible to and what they can do to prevent ill-health. And by the turn of the century it will be commonplace to have a bad combination of genes repaired to avoid disease. A new report compiled by Research Australia with 10 top Australian medical researchers predicts individual gene profiling will revolutionize health care within a decade.

Keywords: top, australian, scientists, predict, major, medical, advances, scientist, advance

« Previous | Next »

Similar news on "10 Top Australian Scientists Predict Major Medical Advances":

Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »
Scientists can predict psychotic illness in up to 80 percent of high-risk youth
01-07-2008 · EurekAlert!
Which at-risk teens will cross the line from having risk factors for psychosis to actually developing a psychotic illness? Researchers have improved the ability to predict who will cross the threshhold from 35 percent accuracy to 65-80 percent accuracy, based on the specific combinations of risk factors a teen has. This level of accuracy is comparable to that for major medical diseases, like diabetes.
Similar news · Read more »
ORNL's Ho Nyung Lee cited as top early career scientist
11-01-2007 · Oak Ridge National Laboratory (ORNL)
Oak Ridge National Laboratory researcher Ho Nyung Lee is one of eight Department of Energy scientists to receive the Presidential Early Career Award for Scientists and Engineers (PECASE).
Similar news · Read more »
Accuracy of thyroid hormone testing improved with state-of-the-art test
07-25-2007 · EurekAlert!
Researchers at Georgetown University Medical Center have developed a fast and accurate way to measure a major hormone released by the thyroid gland -- an advance they say may help in the treatment of many women who have overactive or underactive thyroid glands.
Similar news · Read more »
Jefferson scientists uncover role of cancer stem cell marker: controlling gene expression
01-17-2008 · EurekAlert!
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have made an extraordinary advance in the understanding of the function of a gene previously shown to be part of an 11-gene "signature" that can predict which tumors will be aggressive and likely to spread. The gene, USP22, encodes an enzyme that appears to be crucial for controlling large scale changes in gene expression, one of the hallmarks of cancer cells.
Similar news · Read more »
BCM, Rice make major advance in structural biology
04-30-2007 · EurekAlert!
Scientists from Baylor College of Medicine and Rice University have discovered a new way to analyze the moving parts of large proteins -- a breakthrough that will make it easier for structural biologists to classify and scrutinize the active sites of proteins implicated in cancer and other diseases. The research will appear in the Proceedings of the National Academy of Science.
Similar news · Read more »
UCLA, Italian chemists move closer to solving Lou Gehrig's disease mystery
06-27-2007 · EurekAlert!
Chemists from UCLA and the University of Florence in Italy may have solved an important mystery about a protein that plays a key role in a particular form of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. If scientists can figure out why ALS patients do not have copper or zinc in the protein, that would be a major advance that could lead to treatment.
Similar news · Read more »
Scientists discover key to manipulating fat
07-01-2007 · EurekAlert!
In what they call a "stunning research advance," investigators at Georgetown University Medical Center have been able to use simple, nontoxic chemical injections to add and remove fat in targeted areas on the bodies of laboratory animals. They say the discovery, published online in Nature Medicine on July 1, could revolutionize human cosmetic and reconstructive plastic surgery and treatment of diseases associated with human obesity.
Similar news · Read more »
New treatments have major impact on heart failure rates
05-01-2007 · EurekAlert!
Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment.In the largest study of its kind, research led by the University of Edinburgh, analyzed hospital treatment and outcomes for 44,372 patients admitted to 113 hospitals in 14 countries with heart attacks or unstable angina (threatened heart attacks).
Similar news · Read more »
New diagnostic technologies offer non-invasive means
04-15-2007 · EurekAlert!
Molecular messages and signals circulating in blood or contained in cells lining the airway can identify early stage cancer, according to research reported today at the 2007 Annual Meeting of the American Association for Cancer Research. Scientists looking to apply basic science knowledge to medical practice are developing tests that diagnose, predict or monitor cancer risks, without invasive tissue sampling. Such tests could benefit all, particularly underserved populations, such as the poor, who often wait until symptoms appear before seeing a doctor.
Similar news · Read more »